全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

History of Diabetic Eye Related Diseases

DOI: 10.4236/jdm.2021.115028, PP. 354-358

Keywords: Diabetes Mellitus, Ocular Manifestations, Diabetic Retinopathy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Diabetes mellitus is the number one cause of blindness among adults aged 20 - 64 in the United States. The Center for Disease Control estimates that 9.4% of the US population meets diagnostic criteria for diabetes. Among patients with the disease, over one-fourth will have findings of diabetic retinopathy, ranging from mild non-proliferative diabetic retinopathy (rare dot-blot hemorrhages) to the most severe form, proliferative diabetic retinopathy (PDR). Despite diabetes being recognized as a unique disease entity as early as the 2nd century AD, no physician was capable of identifying the connection between this mysterious endocrine disorder and its ocular manifestations until the 19th century, mainly due to limitations in the ocular examination. As imaging modalities have developed over the decades of research, so have our various treatments; which now include a wide range of options such as anti-VEGF injections, laser treatment, and microsurgeries. Here we review the evolution of imaging modalities, pathophysiology of proliferative vs. non-proliferative diabetic retinopathy complications, and commonly used treatment options.

References

[1]  Kalantzis, G., Angelou, M. and Poulakou-Rebelakou, E. (2006) Diabetic Retinopathy: A Historical Assessment. Hormones, 5, 72-75.
https://doi.org/10.14310/horm.2002.11172
[2]  Wolfensberger, T.J. and Hamilton, P. (2001) Diabetic Retinopathy-An Historical Review. Seminars in Ophthalmology, 16, 2-7.
https://doi.org/10.1076/soph.16.1.2.4220
[3]  Matuszewski, W., Bandurska-Stankiewicz, E., Modzelewski, R., Kamińska, U. and Stefanowicz-Rutkowska, M. (2017) Diagnosis and Treatment of Diabetic Retinopathy-Historical Overview. Clinical Diabetology, 6, 182-188.
https://doi.org/10.5603/DK.2017.0030
[4]  Fine, S.L., Goldberg, M.F. and Tasman, W. (2016) Historical Perspectives on the Management of Macular Degeneration, Diabetic Retinopathy, and Retinal Detachment. American Academy of Ophthalmology, 123, S64-S77.
https://doi.org/10.1016/j.ophtha.2016.04.058
[5]  Mansour, S.E., Browning, D.J., Wong, K., Flynn Jr, H.W. and Bhavsar, A.R. (2020) The Evolving Treatment of Diabetic Retinopathy. Clinical Ophthalmology, 14, 653-678.
https://doi.org/10.2147/OPTH.S236637
[6]  Relhan, N. and Flynn Jr, H.W. (2017) The Early Treatment Diabetic Retinopathy Study Historical Review and Relevance to Today’s Management of Macular Edema. Current Opinion in Ophthalmology, 28, 205-212.
https://doi.org/10.1097/ICU.0000000000000362
[7]  Nguyen, Q.D., Brown, D.M., Marcus, D.M., Boyer, D.S., Patel, S., Feiner, L., Gibson, A., Sy, J., Rundle, A.C., Hopkins, J.J., Rubio, R.G. and Ehrlich, J.S. (2012) Ranibizumab for Diabetic Macular Edema. American Academy of Ophthalmology, 119, 789-801.
https://doi.org/10.1016/j.ophtha.2011.12.039
[8]  Brown, D.M., Nguyen, Q.D., Marcus, D.M., Boyer, D.S., Patel, S., Feiner, L., Schlottmann, P.G., Rundle, A.C., Zhang, J., Rubio, R.G., Adamis, A.P., Ehrlich, J.S. and Hopkins, J.J. (2013) Long-Term Outcomes of Ranibizumab Therapy for Diabetic Macular Edema: The 36-Month Results from Two Phase III Trials. American Academy of Ophthalmology, 120, 2013-2022.
https://doi.org/10.1016/j.ophtha.2013.02.034
[9]  Greco, D., Gambina, F. and Maggio, F. (2009) Ophthalmoplegia in Diabetes Mellitus: A Retrospective Study. Acta Diabetologica, 46, Article No. 23.
https://doi.org/10.1007/s00592-008-0053-8

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133